Chu QS - Search Results

1

A phase I and pharmacokinetic study of lapatinib in combination with letrozole in patients with advanced cancer.

Chu QS, Cianfrocca ME, Goldstein LJ, Gale M, Murray N, Loftiss J, Arya N, Koch KM, Pandite L, Fleming RA, Paul E, Rowinsky EK. Chu QS, et al. Clin Cancer Res. 2008 Jul 15;14(14):4484-90. doi: 10.1158/1078-0432.CCR-07-4417. Clin Cancer Res. 2008. PMID: 18628463 Clinical Trial.

2

Phase I and pharmacokinetic study of tasidotin hydrochloride (ILX651), a third-generation dolastatin-15 analogue, administered weekly for 3 weeks every 28 days in patients with advanced solid tumors.

Mita AC, Hammond LA, Bonate PL, Weiss G, McCreery H, Syed S, Garrison M, Chu QS, DeBono JS, Jones CB, Weitman S, Rowinsky EK. Mita AC, et al. Among authors: chu qs. Clin Cancer Res. 2006 Sep 1;12(17):5207-15. doi: 10.1158/1078-0432.CCR-06-0179. Clin Cancer Res. 2006. PMID: 16951240 Clinical Trial.

3

A phase II and pharmacological study of the matrix metalloproteinase inhibitor (MMPI) COL-3 in patients with advanced soft tissue sarcomas.

Chu QS, Forouzesh B, Syed S, Mita M, Schwartz G, Cooper J, Curtright J, Rowinsky EK. Chu QS, et al. Invest New Drugs. 2007 Aug;25(4):359-67. doi: 10.1007/s10637-006-9031-6. Epub 2007 Jan 20. Invest New Drugs. 2007. PMID: 17237909 Clinical Trial.

4

A phase I and pharmacokinetic study of pemetrexed plus irinotecan in patients with advanced solid malignancies.

Rowinsky EK, Beeram M, Hammond LA, Schwartz G, De Bono J, Forouzesh B, Chu Q, Latz JE, Hong S, John W, Nguyen B. Rowinsky EK, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):532-9. doi: 10.1158/1078-0432.CCR-06-1606. Clin Cancer Res. 2007. PMID: 17255275 Clinical Trial.

5

Phase I and pharmacokinetic study of lapatinib in combination with capecitabine in patients with advanced solid malignancies.

Chu QS, Schwartz G, de Bono J, Smith DA, Koch KM, Versola MJ, Pandite L, Arya N, Curtright J, Fleming RA, Ho PT, Rowinsky EK. Chu QS, et al. J Clin Oncol. 2007 Aug 20;25(24):3753-8. doi: 10.1200/JCO.2007.11.1765. J Clin Oncol. 2007. PMID: 17704424 Clinical Trial.

6

Phase I trial of the novel mammalian target of rapamycin inhibitor deforolimus (AP23573; MK-8669) administered intravenously daily for 5 days every 2 weeks to patients with advanced malignancies.

Mita MM, Mita AC, Chu QS, Rowinsky EK, Fetterly GJ, Goldston M, Patnaik A, Mathews L, Ricart AD, Mays T, Knowles H, Rivera VM, Kreisberg J, Bedrosian CL, Tolcher AW. Mita MM, et al. Among authors: chu qs. J Clin Oncol. 2008 Jan 20;26(3):361-7. doi: 10.1200/JCO.2007.12.0345. J Clin Oncol. 2008. PMID: 18202410 Clinical Trial.

7

Phase I and pharmacokinetic study of trabectedin as a 1- or 3-hour infusion weekly in patients with advanced solid malignancies.

Forouzesh B, Hidalgo M, Chu Q, Mita A, Mita M, Schwartz G, Jimeno J, Gómez J, Alfaro V, Lebedinsky C, Zintl P, Rowinsky EK. Forouzesh B, et al. Clin Cancer Res. 2009 May 15;15(10):3591-9. doi: 10.1158/1078-0432.CCR-08-2889. Epub 2009 May 5. Clin Cancer Res. 2009. PMID: 19417019 Clinical Trial.

8

Satraplatin, an oral platinum, administered on a five-day every-five-week schedule: a pharmacokinetic and food effect study.

Ricart AD, Sarantopoulos J, Calvo E, Chu QS, Greene D, Nathan FE, Petrone ME, Tolcher AW, Papadopoulos KP. Ricart AD, et al. Among authors: chu qs. Clin Cancer Res. 2009 Jun 1;15(11):3866-71. doi: 10.1158/1078-0432.CCR-08-2373. Epub 2009 May 19. Clin Cancer Res. 2009. PMID: 19458055 Clinical Trial.

9

A phase I study of eribulin mesylate (E7389), a mechanistically novel inhibitor of microtubule dynamics, in patients with advanced solid malignancies.

Goel S, Mita AC, Mita M, Rowinsky EK, Chu QS, Wong N, Desjardins C, Fang F, Jansen M, Shuster DE, Mani S, Takimoto CH. Goel S, et al. Among authors: chu qs. Clin Cancer Res. 2009 Jun 15;15(12):4207-12. doi: 10.1158/1078-0432.CCR-08-2429. Epub 2009 Jun 9. Clin Cancer Res. 2009. PMID: 19509177 Clinical Trial.

10

Phase I and pharmacokinetic study of sequential paclitaxel and trabectedin every 2 weeks in patients with advanced solid tumors.

Chu Q, Mita A, Forouzesh B, Tolcher AW, Schwartz G, Nieto A, Soto-Matos A, Alfaro V, Lebedinsky C, Rowinsky EK. Chu Q, et al. Clin Cancer Res. 2010 May 1;16(9):2656-65. doi: 10.1158/1078-0432.CCR-10-0062. Epub 2010 Apr 20. Clin Cancer Res. 2010. PMID: 20406837 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

91 results

Search Page

Filters